Product Description: HIF-PHD-IN-4 (Compound 13) is an orally active PHD2 inhibitor with an IC50 of 100 nM. HIF-PHD-IN-4 can effectively enhance the mobilization of hematopoietic stem cells induced by G-CSF in mice at a dose of 2 mg/kg. HIF-PHD-IN-4 is suitable for research in the field of tumor therapy [1].
Applications: Cancer-programmed cell death
Formula: C20H21N5O3
References: [1]Wu M, et al. Discovery of Novel, Potent, Orally Bioavailable and Efficacious, Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Hematopoietic Stem Cell Mobilization. J Med Chem. 2025 Mar 6.
Molecular Weight: 379.41
Research Area: Cancer
Target: HIF/HIF Prolyl-Hydroxylase